The dichloromethane (DCM) extract of the fruits of Peucedanum schottii Besser ex DC. (Apiaceae) was subjected to high-performance counter-current chromatography (HPCCC) for the efficient and fast separation (30 min) and isolation of cimifugin using an ethyl acetate: water (1:1 v/v, K = 1.01) system. The analytical scale-optimized separation was easily scaled to semi-preparative conditions. Cimifugin (11.25% yield, 96.5% purity) was isolated for the first time from P. schottii and characterized by NMR spectroscopy. Cimifugin and the crude DCM extract were evaluated using ELISA microtiter assays for their inhibitory potential against the cholinesterases (acetylcholinesterase -AChE and butyrylcholinesterase -BChE), and tyrosinase (TYR), which are key enzymes for the treatment of some neurodegenerative diseases, i.e. Alzheimer's and Parkinson's. The crude extract exhibited a weak inhibitory activity against AChE, BChE, and TYR (4.2, 35.5, and 0% at 100 µg mL -1 and 10.3, 40.0, and 12.2% at 200 µg mL -1 , respectively), while cimifugin displayed low to moderate inhibition towards AChE and BChE (3.1 and 21.6%, respectively) at 200 µg mL -1 .
The genus Peucedanum (Apiaceae) is widely distributed in Europe, Asia, and Africa, and comprises more than 120 species [1a] . The aerial and underground parts of several Peucedanum species are used in ethnomedicine for the treatment of cough, cramps, pain, rheumatism, asthma, and angina [1a] . The leaves and roots of P. japonicum Thunb. have been used since ancient times for the treatment of sore throat in Japan and Taiwan. Further reports showed that the aqueous extracts of the mentioned plant also reduced cell proliferation activity in a rat colon carcinogenesis model, suggesting chemopreventive potential [1b] . The roots of P. palustre (L.) Moench. are known to be effective in the treatment of epilepsy and gastrointestinal disorders [1c] . More recently, antiviral (including anti-HIV), antimicrobial, and anti-cholesterol activities were assigned to different extracts from the genus Peucedanum [1d-1f].
Peucedanum species are also known to be a rich source of coumarins, acting on the central nervous system (CNS). P. praereptorum Dunn. was examined as a neuroprotective agent, which led to the isolation of praeruptorin C from the roots, with a protective effect on cultured cortical neuron injury induced by glutamate [2a,2b] . Coumarins from the roots of P. japonicum, such as bergapten, psoralen, xanthotoxin, and praeruptorin A, exerted inhibitory activity against monoamine oxidases A and B (MAO-A and MAO-B) with an IC 50 range of 13.8-40.7 µM [2b,2c]. Among five coumarins from the roots of P. ostruthium (L.) W.D.J. Koch, ostruthol was the most effective as an acetylcholinesterase (AChE) inhibitor in a thin layer chromatography (TLC) bioautographic assay [2d]. In addition to coumarins, chromone derivatives are another important bioactive class of compounds in Peucedanum species. Chromone derivatives exhibit a wide range of pharmacological properties, including antimicrobial, anticancer, antioxidant, antiviral (including HIV), as well as lipoxygenase and cyclooxygenase inhibition, and are active at benzodiazepine receptors and as anticonvulsant agents [2e]. Eugenin, (-)-hamaudol, and (+)-visamminol from the roots of P. japonicum showed antiplatelet aggregation activity, while peucenin from the roots of P. ostruthium inhibited AChE [2d,2f]. Chromone derivatives were found to be effective on some receptors in the CNS. 5-Hydroxy-2-(2-phenylethyl)-chromone from the rhizomes of Imperata cylindrica (L.) P. Beauv. (Poaceae) was demonstrated to act as a selective serotonin (5-hydroxytryptamine) receptor inhibitor for 5-HT 2B (62% at 10 µM) [2g]. 5-Hydroxy-2-(2-phenylethyl)chromone and 5-hydroxy-2-[2-(2-hydroxyphenyl)ethyl]-chromone showed significant neuroprotective activity against glutamateinduced neurotoxicity in primary cultures of rat cortical cells, exhibiting 67 and 63.6% protection, respectively, at 10 µM [2h]. The dihydropyranochromones, e.g. alsaticol, divaricatol, and ledebouriellol were isolated previously from the fruits of P. alsaticum L. in this laboratory [2i,2j].
Although several Peucedanum species have been well investigated, little is known about P. schottii. This study aimed to isolate the major constituent, the furanochromone cimifugin, from P. schottii fruits. Since this group and other researchers previously reported the marked cholinesterase (ChE) inhibitory effect of coumarins and coumarin-rich extracts [3] , the inhibitory activity of this metabolite, as well as the crude extract itself, against cholinesterases (ChEs) and tyrosinase (TYR, E.C. 1.14.18.1) was investigated. To make the compound more available for biological evaluation, an efficient protocol for cimifugin isolation was developed involving high performance counter-current chromatography (HPCCC). This technique, in which one phase of two immiscible solvents is used instead of a solid stationary phase, was employed to achieve a rapid purification. It offers the significant advantages of easy scale-up, minimizes solvent usage and loss of material due to adsorption, and provides a rapid separation time, thereby yielding a pure isolate in minutes rather than hours or days [4, 5] .
The facile isolation of cimifugin from P. schottii fruits is described herein for the first time using HPCCC. The extract and the purified cimifugin were further subjected to high-throughput screening against acetylcholinesterase (AChE, EC 3.1.1.7), butyrylcholinesterase (BChE, EC 3.1.1.8), and TYR, the key enzymes related to Alzheimer's (AD) and Parkinson's diseases (PD). To achieve an effective resolution of the main compound, variable mixtures of heptane, ethyl acetate, methanol, n-butanol, and water (HEMBWat) were evaluated. Partition coefficients (Kval) were calculated, expressed as the concentration of target compounds in the upper stationary phase divided by that in the lower mobile phase. For target compound isolation, an ethyl acetate:water (1:1 v/v) system (Kval = 1.01) was used, and retention of the stationary phase was 79%. Experiments were performed on an analytical scale prior to effective semi-preparative scale-up. The scale-up factor was calculated as 6. Forty-five HPCCC fractions were collected and analyzed by the HPLC-DAD technique and pure target compound was detected in fractions eluting between 22-30 minutes. Complete preparative separation was achieved in 30 min resulting in 135 mg of pure compound from 1.2 g of crude extract injected (repeated 3 times). Spectroscopic data established the isolate as cimifugin [6, 7] of 96.5% purity.
Counter-current chromatography (CCC) has evolved as an effective alternative to conventional chromatographic techniques for the separation of furanochromone derivatives from plant extracts. Previously, Gui et al. [4] applied HPCCC to separate prim-Oglucosylcimifugin, 4'-O-β-D-glucosyl-5-O-methylvisamminol, cimifugin, and sec-O-glucosylhamaudol from the roots of Saposhnikovia divaricata (Turcz.) Schischk. (Apiaceae). Following a series of extraction steps, the n-butanol fraction was subjected to HPCCC using an ethyl acetate, n-butanol, ethanol, and water system (1:1:0.1:2, v/v). Analytical and semi-preparative columns were used, but the isolation time for cimifugin was longer that 60 min, and only 14.1 mg (purity 90.1%) was obtained from 960 mg of n-butanol extract. Enhanced purity was achieved by Li et al. [8] , following chromatography of the n-butanol extract of S. divaricata by reversed phase-medium pressure liquid chromatography (RP-MPLC) and preparative HPCCC. In this instance, 113 mg of cimifugin (95% purity) was obtained from 7.48 g of n-butanol extract. In the present experiments, cimifugin was isolated in a very short time (30 min) directly from the crude extract in a higher yield and purity (11.25%) than previously reported.
Previously mentioned literature data indicate that furanochromone derivatives may have potential CNS activity, and inhibit cholinesterases (AChE and BChE) and TYR. Consequently, the crude extract and cimifugin were examined for their enzyme inhibitory potential using ELISA microtiter assays. The extract showed a low inhibitory activity against AChE, BChE, and TYR (4.2, 35.5, and 0% at 100 µg mL -1 and 10.3, 40.0, and 12.2% at 200 µg mL -1 , respectively). Cimifugin displayed low to moderate inhibitory potential towards AChE and BChE (3.1 and 21.6% respectively) at 200 µg mL -1 (Table 1) . It is important to emphasize, that cimifugin possessed significant selectivity toward BChE.
A promising approach for the symptomatic treatment of mild to moderate AD is to increase the levels of acetylcholine (ACh) and decrease MAO levels, which may inhibit the aggregation of amyloid β-peptide (Aβ) plaques found in AD brains [9] . Natural chromones (1-benzopyran-4-ones) are widely distributed in the plant kingdom and some were evaluated as AChE inhibitors using mostly in vitro assays, such as the spectrophotometric method of Ellman. Three different 2-(2-phenylethyl)chromone derivatives (at 50 µg/mL) inhibited ACh activity at about 30%. Two diepoxytetrahydro-2-(2-phenylethyl)-chromones, i.e. oxidoagarochromone A and B, showed marginally stronger activity (40-46%) [10] . An examination of coumarins and chromone derivatives as noncompetitive inhibitors of AChE (at 3-100 µM) indicated that replacing the coumarin nucleus by an isomeric chromone results in a loss of activity toward both enzymes. Moreover, this modification can lead to mixed-type of inhibition of AChE [9] . In the present experiments, cimifugin exhibited no activity at a concentration of 100 µg mL -1 , whereas it caused weak inhibition toward AChE at the higher concentration of 200 µg mL -1 . Inhibitory action against BChE was seven times stronger, but still low when compared with the reference drug (Table 1) Another enzyme which is important in neurodegenerative diseases is TYR, responsible for the conversion of tyrosine to L-dopa, and which may eventually provoke the neurotoxicity associated with PD. A series of chromone derivatives were evaluated for TYR inhibitory activity. 5-Methyl-7-methoxy-2-(2'-benzyl-3'-oxobutyl)chromone exhibited the strongest activity, and higher than the reference (IC 50 0.03 and 0.09 mM for kojic acid, respectively). According to kinetic analysis, it is a competitive inhibitor with TYR for the L-tyrosine binding site [11] . No activity was observed for cimifugin in the present assays. Only a weak activity was observed for the crude extract, and some other compounds could be considered to share responsibility towards low inhibition of TYR (Table 1) .
As oxidative stress and free radical formation are strongly associated with the pathogenesis of neurodegenerative diseases, it is important to test both the extracts of medicinal plants, and pure isolates for antioxidant activity. Chromone derivatives, such as 11-hydroxy-sec-O-glucosylhamaudol, sec-O-glucosylhamaudol, prim-O-glucosylcimifugin, and cimifugin isolated from the roots of Ostericum koreanum (Maxim.) Kitag. (Apiaceae) did not show Cimifugin from Peucedanum schottii and its enzyme inhibitory activity Natural Product Communications Vol. 11 (8) 2016 1109 antioxidant activity in the DPPH radical and superoxide anion radical scavenging assay systems (IC 50 > 50 µg mL -1 ) [12] , thus, further assays were not performed.
In conclusion, cimifugin was isolated for the first time from P. schottii fruits, and an efficient and rapid protocol for isolation using HPCCC was developed. The crude extract of P. schottii showed weak inhibitory activity against AChE, BChE, and TYR, while cimifugin displayed low to moderate inhibition towards AChE and BChE at 200 µg mL -1 . Cimifugin displayed some selectivity towards BChE rather than AChE.
Experimental
Equipment: A commercially available Spectrum HPCCC (Dynamic Extractions, Slough, UK), equipped with polytetrafluoroethylene multilayer coils for both analytical and semi-preparative scale analysis, was used in this study. An analytical coil of 0.8 mm bore, 22 mL capacity, and a 1 mL sample loop was used. For semipreparative purposes, a coil (136 mL), 1.6 mm bore, and a 6 mL sample loop was used. The chromatograph was connected to a Sapphire UV detector and Alpha 10 pump (ECOM, Prague, Czech Republic). The apparatus was run at the maximum rotation speed (1600 rpm) to obtain the optimum centrifugal force (240×g). The HPLC analysis of extract and collected fractions was performed on a Shimadzu high performance liquid chromatograph model SPD M20 IVP (Shimadzu, Japan) with membrane degasser (DGU-20A 3R), binary pump (LC-20AD), autosampler (SIL-20A HT), and DAD detector. A Phenomenex Synergi 4u Fusion-RP (250 mm× 4.6 mm, 5 μm) column was used.
Reagents and chemicals:
All organic solvents used to obtain the biphasic system and the dichloromethane (DCM) used for the preparation of the extract from the plant material were of analytical grade and purchased from POCh (Gliwice, Poland). Water was purified using a Millipore Laboratory Ultrapure Water System (Millipore, France). Methanol (HPLC grade) was supplied from J.T. Baker, Germany. CH 3 OH-d 4 (99.8%) and CHCl 3 -d 4 (99.8%) were purchased from Deutero GmbH (Kastellaun, Germany), while trimethyl silylpropionic acid sodium salt-d 4 (TSPA-d 4 ) was supplied by Sigma-Aldrich. 
Plant material and extraction:

Selection of two-phase system:
The composition of the two-phase solvent system was selected according to the partition coefficient (K) and peak resolution of the target compound based on different ratios of heptane, ethyl acetate, n-butanol, methanol, and water (HEMBWat). Four mixtures of HEMBWat were prepared as described previously [13] . A sample (1 mg) of crude extract was added to a test tube containing each phase (2 mL) of the test twophase solvent systems and shaken for 1 min. Equal volumes (0.5 mL) of upper and lower phases were evaporated separately, the residues dissolved in methanol (1 mL), and then analysed by HPLC. The HEMBWat mixture selected for the CCC purification was thoroughly equilibrated at room temperature and the 2 phases were separated immediately before use. The upper phase was used as the stationary phase and the lower phase as the mobile phase in a reversed phase mode.
Separation procedure: Optimal conditions for the separation were developed on an analytical, then semi-preparative scale. A constant temperature of 30ºC was established during the experiment. The multilayer coil was filled initially with the upper stationary phase and the rotation speed set to 1600 rpm. Mobile phase was introduced at a flow speed of 1 mL min -1 for the analytical and 6 mL min -1 for the semi-preparative scale runs. When no more of the stationary phase eluted from the coil, equilibrium was reached. The volume of displaced stationary phase permitted calculation of the retention of the stationary phase in the coil. A sample solution comprised the DCM extract of the fruits (65 mg) of P. schottii dissolved in the solvent system (1 mL, 0.5 mL upper and 0.5 mL lower phase) for analytical purposes, and a sample (400 mg) was dissolved in the biphasic system (6 mL) for semi-preparative purposes. The effluent from the column was monitored with a UV absorbance detector at 254 nm. One minute fractions were collected, evaporated, dissolved in methanol, and analyzed by HPLC with diode array detection (DAD).
HPLC-DAD and NMR analysis for identification of HPCCC fractions:
An HPLC-DAD system was used for the analysis of the extract and all collected fractions. Samples were separated on a Phenomenex Synergi 4u Fusion-RP (250 mm × 4.6 mm, 5 μm) column using a stepwise mobile phase gradient prepared from methanol (A) and water (B). The gradient was: 0 min, 50% A in B; 5 min, 60% A in B; 25 min, 80% A in B; 30-40 min, 100% A. The flow rate was 1 mL min -1 , the column temperature was 25°C, and the injection volume was 10 μL. Fractions containing pure compounds were collected and subjected to NMR analysis. 1 H and 13 C NMR spectra were recorded on a Bruker AVII+ 600 spectrometer (Bruker, Karlsruhe, Germany), in CHCl 3 -d 4 and CH 3 OH-d 4 . The isolated compound was identified as cimifugin [6, 7] .
AChE and BChE inhibitory assays:
The AChE and BChE inhibitory activities were determined by the spectrophotometric method of Ellman et al. [14] , with some modification [15] . Electric eel AChE (Type-VI-S, EC 3.1.1.7, Sigma) and horse serum BChE (EC 3.1.1.8, Sigma) were used, and acetylthiocholine iodide and butyrylthiocholine chloride (Sigma) were employed as substrates for the reactions, respectively. 5,5´-Dithio-bis(2-nitrobenzoic)acid (DTNB, Sigma) was used for measuring the cholinesterase activity. The hydrolysis of acetylthiocholine iodide/butyrylthiocholine chloride was monitored at 412 nm for the formation of the yellow 5thio-2-nitrobenzoate anion as a result of the reaction of DTNB with thiocholines, catalyzed by the enzyme utilizing a 96-well microplate reader (VersaMax, Molecular Devices, Sunnyvale, CA, USA). The percentage inhibition of AChE/BChE was determined by comparison of the reaction rates of samples relative to blank (ethanol in phosphate buffer pH=8) using the formula (E−S) × 100/E, where E is the activity of enzyme without test sample and S is the activity of the enzyme with test sample. Experiments were performed in triplicate. Galanthamine (Sigma) was employed as a positive reference compound.
TYR inhibitory activity assay:
Inhibition of TYR (EC 1.14.1.8.1, 30 U, mushroom tyrosinase, Sigma) was determined using the modified dopachrome method with L-DOPA as substrate [16] . Assays were conducted in a 96-well microplate using an ELISA microplate reader (VersaMax Molecular Devices, Sunnyvale, CA, USA) to measure the absorbance at 475 nm. An aliquot of the samples dissolved in DMSO with phosphate buffer (80 μL, pH 6.8), TYR (40 μL), and L-DOPA (40 μL) were placed in each well. Results were compared with the blank control (DMSO), while αkojic acid (Sigma) was used as the positive control. The percentage TYR inhibition (I %) was calculated as follows: I % = (Absorbance control -Absorbance sample) × 100/Absorbance control.
